Company Search:
Advanced Search
Sponsored Links
Ibio, Incorporation Company Snapshot
Ibio, Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ibio, Incorporation with three other companies in this sector in the United States: Abeona Therapeutics Inc (2016 sales of $889,000.00 ), Cyclacel Pharmaceuticals, Inc. ($843,000.00 of which 100% was Pharmaceutical Products), and Stemline Therapeutics Inc ($1.04 million of which 100% was Bio-Pharmaceutical).

Sales Analysis. During the year ended June of 2016, sales at Ibio, Incorporation were $948,000.00 . This is a sharp decrease of 48.8% versus 2015, when the company's sales were $1.85 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ibio, Incorporation
  Stock Performance Chart for Ibio, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (8/11/2017): .30
(Figures in U.S. Dollars)
1 Week -12.3%   13 Weeks -17.7%  
4 Weeks -21.3%   52 Weeks -54.2%  
Ibio, Incorporation Key Data:
  Ticker: IBIO Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 948,000
(Year Ending Jan 2017).
Employees: 7
  Currency: U.S. Dollars Market Cap: 26,557,316
  Fiscal Yr Ends: June Shares Outstanding: 89,118,510
  Share Type: Common Closely Held Shares: 49,845,405
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.